{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:02:49Z","timestamp":1777654969912,"version":"3.51.4"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL133574 OT2HL152643 T32HL134622"],"award-info":[{"award-number":["R01HL133574 OT2HL152643 T32HL134622"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CAREER Award 1552782"],"award-info":[{"award-number":["CAREER Award 1552782"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Red blood cell (RBC) deformability is a valuable hemorheological biomarker that can be used to assess the clinical status and response to therapy of individuals with sickle cell disease (SCD). RBC deformability has been measured by ektacytometry for decades, which uses shear or osmolar stress. However, ektacytometry is a population based measurement that does not detect small-fractions of abnormal RBCs. A single cell-based, functional RBC deformability assay would complement ektacytometry and provide additional information. Here, we tested the relative merits of the OcclusionChip, which measures RBC deformability by microcapillary occlusion, and ektacytometry. We tested samples containing glutaraldehyde-stiffened RBCs for up to 1% volume fraction; ektacytometry detected no significant change in Elongation Index (EI), while the OcclusionChip showed significant differences in Occlusion Index (OI). OcclusionChip detected a significant increase in OI in RBCs from an individual with sickle cell trait (SCT) and from a subject with SCD who received allogeneic hematopoietic stem cell transplant (HSCT), as the sample was taken from normoxic (pO2:159\u00a0mmHg) to physiologic hypoxic (pO2:45\u00a0mmHg) conditions. Oxygen gradient ektacytometry detected no difference in EI for SCT or HSCT. These results suggest that the single cell-based OcclusionChip enables detection of sickle hemoglobin (HbS)-related RBC abnormalities in SCT and SCD, particularly when the HbS level is low. We conclude that the OcclusionChip is complementary to the population based ektacytometry assays, and providing additional sensitivity and capacity to detect modest abnormalities in red cell function or small populations of abnormal red cells.<\/jats:p>","DOI":"10.3389\/fphys.2022.954106","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T07:22:40Z","timestamp":1661412160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["OcclusionChip: A functional microcapillary occlusion assay complementary to ektacytometry for detection of small-fraction red blood cells with abnormal deformability"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuncheng","family":"Man","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karamoja","family":"Monchamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Sekyonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Kucukal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Wulftange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utku","family":"Goreke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien A.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut A.","family":"Gurkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/17434440.2016.1254038","article-title":"Emerging point-of-care technologies for sickle cell disease screening and monitoring","volume":"13","author":"Alapan","year":"","journal-title":"Expert Rev. Med. Devices"},{"key":"B2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trsl.2016.03.008","article-title":"Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease","volume":"173","author":"Alapan","year":"","journal-title":"Transl. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1038\/srep07173","article-title":"Heterogeneous red blood cell adhesion and deformability in sickle cell disease","volume":"4","author":"Alapan","year":"2014","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1039\/d0lc01235a","article-title":"Emerging point-of-care technologies for anemia detection","volume":"21","author":"An","year":"2021","journal-title":"Lab. Chip"},{"key":"B5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","article-title":"Sickle cell biomechanics","volume":"12","author":"Barabino","year":"2010","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1152\/japplphysiol.00886.2007","article-title":"Re: point:counterpoint: sickle cell trait should\/should not be considered asymptomatic and as a benign condition during physical activity.","volume":"103","author":"Baskurt","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40265-019-01254-2","article-title":"Crizanlizumab: first approval","volume":"80","author":"Blair","year":"","journal-title":"Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40265-020-01262-7","article-title":"Voxelotor: first approval","volume":"80","author":"Blair","year":"","journal-title":"Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1001\/archpedi.154.9.900","article-title":"Pulse oximetry is a poor predictor of hypoxemia in stable children with sickle cell disease","volume":"154","author":"Blaisdell","year":"2000","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood.v65.1.183.bloodjournal651183","article-title":"Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes","volume":"65","author":"Brittenham","year":"1985","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.18553\/jmcp.2020.20009","article-title":"The economic burden of end-organ damage among medicaid patients with sickle cell disease in the United States: a population-based longitudinal claims study","volume":"26","author":"Campbell","year":"2020","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100637","DOI":"10.1016\/j.blre.2019.100637","article-title":"Not all red cells sickle the same: contributions of the reticulocyte to disease pathology in sickle cell anemia","volume":"40","author":"Carden","year":"2020","journal-title":"Blood Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3324\/haematol.2018.207357","article-title":"Emerging disease-modifying therapies for sickle cell disease","volume":"104","author":"Carden","year":"2019","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/mi10090593","article-title":"Blood cells separation and sorting techniques of passive microfluidic devices: from fabrication to applications","volume":"10","author":"Catarino","year":"2019","journal-title":"Micromachines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bcmd.2015.09.001","article-title":"Diagnostic tool for red blood cell membrane disorders: assessment of a new generation ektacytometer","volume":"56","author":"Da Costa","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0268-960x(02)00074-7","article-title":"The role of hydroxyurea in the management of sickle cell disease","volume":"17","author":"Davies","year":"2003","journal-title":"Blood Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1073\/pnas.1424111112","article-title":"Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis","volume":"112","author":"Du","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20406207211001136","DOI":"10.1177\/20406207211001136","article-title":"Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor","volume":"12","author":"Glaros","year":"2021","journal-title":"Ther. Adv. Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/clinchem\/26.10.1435","article-title":"New optical technique for measuring erythrocyte deformability with the ektacytometer","volume":"26","author":"Groner","year":"1980","journal-title":"Clin. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MOH.0000000000000639","article-title":"Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology","volume":"28","author":"Gurkan","year":"2021","journal-title":"Curr. Opin. Hematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15519","DOI":"10.1039\/d1ra01948a","article-title":"Quantifying the influences of radiation therapy on deformability of human red blood cells by dual-beam optical tweezers","volume":"11","author":"Inanc","year":"2021","journal-title":"RSC Adv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e12374","DOI":"10.1111\/micc.12374","article-title":"Hypoxia-enhanced adhesion of red blood cells in microscale flow","volume":"24","author":"Kim","year":"2017","journal-title":"Microcirculation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/ajh.25933","article-title":"Whole blood viscosity and red blood cell adhesion: potential biomarkers for targeted and curative therapies in sickle cell disease","volume":"95","author":"Kucukal","year":"2020","journal-title":"Am. J. Hematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jbiomech.2016.11.022","article-title":"Biomechanics and biorheology of red blood cells in sickle cell anemia","volume":"50","author":"Li","year":"2017","journal-title":"J. Biomech."},{"key":"B25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejogrb.2006.08.009","article-title":"White blood cell count as a predictor of the severity of sickle cell disease during pregnancy","volume":"133","author":"Litos","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"633080","DOI":"10.3389\/fphys.2021.633080","article-title":"Concurrent assessment of deformability and adhesiveness of sickle red blood cells by measuring perfusion of an adhesive artificial microvascular network","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1535370219900494","article-title":"Blood rheology biomarkers in sickle cell disease","volume":"245","author":"Lu","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102424","DOI":"10.1016\/j.bcmd.2020.102424","article-title":"Leukocyte adhesion to P-selectin and the inhibitory role of crizanlizumab in sickle cell disease: a standardized microfluidic assessment","volume":"83","author":"Man","year":"","journal-title":"Blood Cells Mol. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1111\/micc.12662","article-title":"Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease","volume":"28","author":"Man","year":"","journal-title":"Microcirculation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1039\/d0lc00112k","article-title":"Microfluidic assessment of red blood cell mediated microvascular occlusion","volume":"20","author":"Man","year":"","journal-title":"Lab. Chip"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1039\/d0lc01133a","article-title":"Microfluidic electrical impedance assessment of red blood cell-mediated microvascular occlusion","volume":"21","author":"Man","year":"","journal-title":"Lab. Chip"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood.2021011151","article-title":"P-Selectin and sickle cell disease: a balancing act","volume":"137","author":"Manwani","year":"2021","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1182\/blood-2008-07-161166","article-title":"Red cell membrane: past, present, and future","volume":"112","author":"Mohandas","year":"2008","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.seminhematol.2018.04.007","article-title":"Novel sickle cell disease therapies: targeting pathways downstream of sickling","volume":"55","author":"Morrone","year":"2018","journal-title":"Semin. Hematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-bioeng-091520-025358","article-title":"Vascularized microfluidics and their untapped potential for discovery in diseases of the microvasculature","volume":"23","author":"Myers","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"B37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjh.17975","article-title":"Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia","volume":"197","author":"Nardo-Marino","year":"2021","journal-title":"Br. J. Haematol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjh.16671","article-title":"Inhibition of band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease","volume":"190","author":"Noomuna","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"56910","DOI":"10.3791\/56910","article-title":"Measuring deformability and red cell heterogeneity in blood by ektacytometry","volume":"131","author":"Parrow","year":"2018","journal-title":"J. Vis. Exp."},{"key":"B40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41598-020-79710-3","article-title":"Microfluidic capillary networks are more sensitive than ektacytometry to the decline of red blood cell deformability induced by storage","volume":"11","author":"Piety","year":"2021","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1039\/d1lc00598g","article-title":"In vitro assay for single-cell characterization of impaired deformability in red blood cells under recurrent episodes of hypoxia","volume":"21","author":"Qiang","year":"2021","journal-title":"Lab. Chip"},{"key":"B43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41551-018-0224-z","article-title":"Microvasculature-on-a-chip for the long-term study of endothelial barrier dysfunction and microvascular obstruction in disease","volume":"2","author":"Qiu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"B44","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1002\/ajh.25655","article-title":"Methodological aspects of the oxygenscan in sickle cell disease: a need for standardization","volume":"95","author":"Rab","year":"2020","journal-title":"Am. J. Hematol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1002\/ajh.26031","article-title":"Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease","volume":"96","author":"Rab","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ajh.25443","article-title":"Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients","volume":"94","author":"Rab","year":"2019","journal-title":"Am. J. Hematol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/CH-151979","article-title":"Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia","volume":"62","author":"Renoux","year":"2016","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"636609","DOI":"10.3389\/fphys.2021.636609","article-title":"Automated oxygen gradient ektacytometry: a novel biomarker in sickle cell anemia","volume":"12","author":"Sadaf","year":"2021","journal-title":"Front. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1039\/b601554a","article-title":"Direct measurement of the impact of impaired erythrocyte deformability on microvascular network perfusion in a microfluidic device","volume":"6","author":"Shevkoplyas","year":"2006","journal-title":"Lab. Chip"},{"key":"B52","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1126\/science.164.3880.717","article-title":"Deformation of red blood cells in capillaries","volume":"164","author":"Skalak","year":"1969","journal-title":"Science"},{"key":"B53","first-page":"1","volume-title":"Bioanalytical method validation guidance for industry","year":"2018"},{"key":"B54","doi-asserted-by":"publisher","first-page":"123ra26","DOI":"10.1126\/scitranslmed.3002738","article-title":"A biophysical indicator of vaso-occlusive risk in sickle cell disease","volume":"4","author":"Wood","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-8155-1579-1.50014-8","volume-title":"Hot embossing: Theory and technology of microreplication","author":"Worgull","year":"2009"},{"key":"B56","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.954106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T07:22:46Z","timestamp":1661412166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.954106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":56,"alternative-id":["10.3389\/fphys.2022.954106"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.954106","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"954106"}}